Morning Market Losers By: Benzinga via Benzinga April 27, 2015 at 09:53 AM EDT Celladon Corp (NASDAQ: CLDN) shares dipped 78.95 percent to $2.88 on the failed CUPID2 trial of MYDICAR in advanced heart ... Read More >> Related Stocks: Akorn Inc Applied Materials Deutsche Bank Ag Marvell Technology Inc Silicom Ltd Tokyo Electron Ltd ADR